Navigation Links
Silk microneedles deliver controlled-release drugs painlessly
Date:12/21/2011

ug delivery mechanism. But their development has been limited by constraints ranging from harsh manufacturing requirements that destroy sensitive biochemicals, to the inability to precisely control drug release or deliver sufficient drug volume, to problems with infections due to the small skin punctures.

The process developed by the Tufts bioengineers addresses all of these limitations. The process involves ambient pressure and temperature and aqueous processing. Aluminum microneedle molding masters were fabricated into needle arrays of about 500 m needle height and tip radii of less than 10 m. The elastomer polydimethylsiloxane (PDMS) was cast over the master to create a negative mold; a drug-loaded silk protein solution was then cast over the mold. When the silk was dry, the drug-impregnated silk microneedles were removed. Further processing through water vapor annealing and various temperature, mechanical and electronic exposures provided control over the diffusity of the silk microneedles and drug release kinetics.

"Changing the structure of the secondary silk protein enables us to 'pre-program' the properties of the microneedles with great precision," said David L. Kaplan, Ph.D., coauthor of the study, chair of biomedical engineering at Tufts and a leading researcher on silk and other novel biomaterials. "This is a very flexible technology that can be scaled up or down, shipped and stored without refrigeration and administered as easily as a patch or bandage. We believe the potential is enormous."


'/>"/>
Contact: Kim Thurler
kim.thurler@tufts.edu
617-627-3175
Tufts University
Source:Eurekalert

Page: 1 2

Related biology news :

1. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
2. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
3. Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency
4. RNA molecules, delivery system improve vaccine responses, effectiveness
5. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
6. Depression during pregnancy can double risk of preterm delivery
7. New type of vaccines deliver stronger and faster immune response
8. MIT: Jeremy Nathans to deliver Scolnick Prize lecture
9. Nanotechnology holds promise for STD drug delivery
10. Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry
11. Bulls-eye electrode helps interpret thoughts, deliver stimulus to aid paralyzed, epileptic patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Polarstern has returned today to Bremerhaven from the Arctic ... ever both the Northeast and the Northwest Passages and ... the research vessel,s 23rd Arctic expedition, operated by the ... journey on August 12th in Reykjavik and ended it ...
... MADISON, WI, OCTOBER 20, 2008 -- The widespread use of ... decades, with little knowledge of the long-term effects on the ... study show that samples taken from over 300 wells across ... contamination. The news is a result of a decadal long ...
... LEDs may help ... Researchers in Germany are describing a potential alternative ... Their study, scheduled for the November 5 issue of ... journal, reports that high intensity visible light from light ...
Cached Biology News:Research around the North Pole 2Research around the North Pole 3Pesticide concentrations decreasing 2American Chemical Society Weekly PressPac Oct. 15, 2008 2American Chemical Society Weekly PressPac Oct. 15, 2008 3American Chemical Society Weekly PressPac Oct. 15, 2008 4American Chemical Society Weekly PressPac Oct. 15, 2008 5American Chemical Society Weekly PressPac Oct. 15, 2008 6American Chemical Society Weekly PressPac Oct. 15, 2008 7American Chemical Society Weekly PressPac Oct. 15, 2008 8
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, ... provider of health care services and one of ... today announced that its parent company and sole ... agreement with Medical Properties Trust, Inc. ("MPT") (NYSE: ... for $900 million in cash.  The transaction is expected to ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a professional and ... basic overview of the industry including definitions, classifications, applications and industry chain structure. ... competitive landscape analysis, and key regions development status. Development policies and plans are ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... announced a new video: 3 Ways to GHS Labels . This video ... the Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With the ...
(Date:7/27/2015)... -- Research presented at the 2015 AACC Annual Meeting ... that led to a fingerprick Ebola test becoming the ... receive approval from the World Health Organization (WHO). This ... West Africa by identifying suspected ... isolate and treat these patients much faster than is ...
Breaking Biology Technology:Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Brady Releases “3 Roads to GHS Labels” Video 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... Boston Scientific,Corporation (NYSE: BSX ) today announced ... Drug Administration (FDA) to market its second-generation,TAXUS(R) Liberte(R) ... the TAXUS Liberte stent early next month in ... its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel-Eluting Coronary Stent System, which ...
... Beike,Biotechnology Co. Ltd., ( http://www.beikebiotech.com ) ... through evidence-based medicine, announced,today it has signed eight ... the world,s most outstanding stem cell research organizations.,As ... a "Stem Cell Expert,Advisory Committee" and a separate ...
... WILMINGTON, Del., Oct. 10 AstraZeneca (NYSE:,AZN) today ... (FDA) has,approved once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended-Release,Tablets ... associated with,bipolar disorder, the manic and mixed episodes ... of bipolar I disorder as adjunctive,therapy to lithium ...
Cached Biology Technology:Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9
ANTI END CEL LUNG AG...
EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
RABBIT ANTI NEOPTERIN...
Biology Products: